HEADER BLOOD CLOTTING 04-OCT-05 2B7D TITLE FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL TITLE 2 PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN A BABOON TITLE 3 THROMBOSIS MODEL COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR VII; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: LIGHT CHAIN; COMPND 5 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 6 PROCONVERTIN, EPTACOG ALFA; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COAGULATION FACTOR VII; COMPND 10 CHAIN: H; COMPND 11 FRAGMENT: HEAVY CHAIN; COMPND 12 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 13 PROCONVERTIN, EPTACOG ALFA; COMPND 14 EC: 3.4.21.21; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: TISSUE FACTOR; COMPND 18 CHAIN: T; COMPND 19 SYNONYM: TF, COAGULATION FACTOR III, THROMBOPLASTIN, CD142 ANTIGEN; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F7; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK 293; SOURCE 10 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1573; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: F7; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 19 EXPRESSION_SYSTEM_CELL_LINE: HEK 293; SOURCE 20 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1573; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 GENE: F3; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SHORT HYDROGEN BOND, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR W.B.YOUNG,J.MORDENTI,S.TORKELSON,W.D.SHRADER,A.KOLESNIKOV,R.RAI, AUTHOR 2 L.LIU,H.HU,E.M.LEAHY,M.J.GREEN,P.A.SPRENGELER,B.A.KATZ,C.YU, AUTHOR 3 J.W.JANC,K.C.ELROD,U.M.MARZEC,S.R.HANSON REVDAT 4 11-OCT-17 2B7D 1 REMARK REVDAT 3 24-FEB-09 2B7D 1 VERSN REVDAT 2 21-MAR-06 2B7D 1 JRNL REVDAT 1 14-FEB-06 2B7D 0 JRNL AUTH W.B.YOUNG,J.MORDENTI,S.TORKELSON,W.D.SHRADER,A.KOLESNIKOV, JRNL AUTH 2 R.RAI,L.LIU,H.HU,E.M.LEAHY,M.J.GREEN,P.A.SPRENGELER, JRNL AUTH 3 B.A.KATZ,C.YU,J.W.JANC,K.C.ELROD,U.M.MARZEC,S.R.HANSON JRNL TITL FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL JRNL TITL 2 PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN AN JRNL TITL 3 ARTERIAL BABOON THROMBOSIS MODEL. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 2037 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16412633 JRNL DOI 10.1016/J.BMCL.2005.12.059 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 38857 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3892 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3874 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.019 REMARK 3 BOND ANGLES (DEGREES) : 3.980 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.70 REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2B7D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000034766. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46266 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-SIGHT, ACCELRYS REMARK 200 STARTING MODEL: 1DAN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRATE, 16-18 % PEG 5K MME, PH REMARK 280 7.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.51500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA L 1 REMARK 465 ASN L 2 REMARK 465 ALA L 3 REMARK 465 PHE L 4 REMARK 465 LEU L 5 REMARK 465 GLU L 6 REMARK 465 GLU L 7 REMARK 465 LEU L 8 REMARK 465 ARG L 9 REMARK 465 PRO L 10 REMARK 465 GLY L 11 REMARK 465 SER L 12 REMARK 465 LEU L 13 REMARK 465 GLU L 14 REMARK 465 ARG L 15 REMARK 465 GLU L 16 REMARK 465 CYS L 17 REMARK 465 LYS L 18 REMARK 465 GLU L 19 REMARK 465 GLU L 20 REMARK 465 GLN L 21 REMARK 465 CYS L 22 REMARK 465 SER L 23 REMARK 465 PHE L 24 REMARK 465 GLU L 25 REMARK 465 GLU L 26 REMARK 465 ALA L 27 REMARK 465 ARG L 28 REMARK 465 GLU L 29 REMARK 465 ILE L 30 REMARK 465 PHE L 31 REMARK 465 LYS L 32 REMARK 465 ASP L 33 REMARK 465 ALA L 34 REMARK 465 GLU L 35 REMARK 465 ARG L 36 REMARK 465 THR L 37 REMARK 465 LYS L 38 REMARK 465 LEU L 39 REMARK 465 PHE L 40 REMARK 465 TRP L 41 REMARK 465 ILE L 42 REMARK 465 SER L 43 REMARK 465 TYR L 44 REMARK 465 SER L 45 REMARK 465 ASP L 46 REMARK 465 GLY L 47 REMARK 465 ASP L 48 REMARK 465 LYS L 143 REMARK 465 ARG L 144 REMARK 465 ASN L 145 REMARK 465 ALA L 146 REMARK 465 SER L 147 REMARK 465 LYS L 148 REMARK 465 PRO L 149 REMARK 465 GLN L 150 REMARK 465 GLY L 151 REMARK 465 ARG L 152 REMARK 465 GLY T 2 REMARK 465 THR T 3 REMARK 465 THR T 4 REMARK 465 ASN T 5 REMARK 465 GLN T 110 REMARK 465 PRO T 111 REMARK 465 THR T 112 REMARK 465 ILE T 113 REMARK 465 GLN T 114 REMARK 465 SER T 115 REMARK 465 PHE T 116 REMARK 465 GLU T 117 REMARK 465 GLN T 118 REMARK 465 VAL T 119 REMARK 465 GLY T 120 REMARK 465 THR T 121 REMARK 465 LYS T 122 REMARK 465 VAL T 123 REMARK 465 ASN T 124 REMARK 465 VAL T 125 REMARK 465 THR T 126 REMARK 465 VAL T 127 REMARK 465 GLU T 128 REMARK 465 TYR T 156 REMARK 465 TYR T 157 REMARK 465 TRP T 158 REMARK 465 LYS T 159 REMARK 465 SER T 160 REMARK 465 SER T 161 REMARK 465 SER T 162 REMARK 465 SER T 163 REMARK 465 GLY T 164 REMARK 465 LYS T 165 REMARK 465 LYS T 166 REMARK 465 THR T 167 REMARK 465 ALA T 168 REMARK 465 LYS T 169 REMARK 465 THR T 170 REMARK 465 ASN T 171 REMARK 465 THR T 172 REMARK 465 ASN T 173 REMARK 465 GLU T 174 REMARK 465 PHE T 175 REMARK 465 LEU T 176 REMARK 465 ILE T 177 REMARK 465 ASP T 178 REMARK 465 VAL T 179 REMARK 465 ASP T 180 REMARK 465 LYS T 181 REMARK 465 GLY T 182 REMARK 465 GLU T 183 REMARK 465 ASN T 184 REMARK 465 TYR T 185 REMARK 465 CYS T 186 REMARK 465 PHE T 187 REMARK 465 PRO T 206 REMARK 465 VAL T 207 REMARK 465 GLU T 208 REMARK 465 CYS T 209 REMARK 465 MET T 210 REMARK 465 GLY T 211 REMARK 465 GLN T 212 REMARK 465 GLU T 213 REMARK 465 LYS T 214 REMARK 465 GLY T 215 REMARK 465 GLU T 216 REMARK 465 PHE T 217 REMARK 465 ARG T 218 REMARK 465 GLU T 219 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O6' C1B H 258 O HOH H 391 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS L 114 CA CYS L 114 CB -0.087 REMARK 500 HIS L 115 CG HIS L 115 ND1 -0.092 REMARK 500 CYS H 58 CA CYS H 58 CB -0.095 REMARK 500 HIS H 71 NE2 HIS H 71 CD2 -0.082 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS L 61 CA - CB - SG ANGL. DEV. = 7.4 DEGREES REMARK 500 CYS L 102 CA - CB - SG ANGL. DEV. = 8.5 DEGREES REMARK 500 ARG L 113 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 TYR L 118 CB - CG - CD2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ASP L 123 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 CYS L 135 CA - CB - SG ANGL. DEV. = 7.1 DEGREES REMARK 500 TRP H 29 CG - CD1 - NE1 ANGL. DEV. = -8.2 DEGREES REMARK 500 TRP H 29 CD1 - NE1 - CE2 ANGL. DEV. = 9.0 DEGREES REMARK 500 TRP H 29 NE1 - CE2 - CZ2 ANGL. DEV. = 6.9 DEGREES REMARK 500 TRP H 51 CG - CD1 - NE1 ANGL. DEV. = -6.8 DEGREES REMARK 500 TRP H 51 CD1 - NE1 - CE2 ANGL. DEV. = 8.3 DEGREES REMARK 500 TRP H 61 CG - CD1 - NE1 ANGL. DEV. = -8.0 DEGREES REMARK 500 TRP H 61 CD1 - NE1 - CE2 ANGL. DEV. = 9.2 DEGREES REMARK 500 TRP H 61 NE1 - CE2 - CZ2 ANGL. DEV. = 8.5 DEGREES REMARK 500 TRP H 61 NE1 - CE2 - CD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 THR H 115 OG1 - CB - CG2 ANGL. DEV. = -14.3 DEGREES REMARK 500 VAL H 129G N - CA - C ANGL. DEV. = -19.6 DEGREES REMARK 500 ARG H 134 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 TRP H 141 CG - CD1 - NE1 ANGL. DEV. = -6.5 DEGREES REMARK 500 TRP H 141 CD1 - NE1 - CE2 ANGL. DEV. = 7.6 DEGREES REMARK 500 TRP H 141 NE1 - CE2 - CZ2 ANGL. DEV. = 8.2 DEGREES REMARK 500 ARG H 147 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG H 162 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 GLY H 170F N - CA - C ANGL. DEV. = -16.5 DEGREES REMARK 500 CYS H 182 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 TYR H 184 CB - CG - CD2 ANGL. DEV. = -4.2 DEGREES REMARK 500 SER H 190 CA - CB - OG ANGL. DEV. = -16.6 DEGREES REMARK 500 HIS H 199 N - CA - C ANGL. DEV. = -20.9 DEGREES REMARK 500 TRP H 207 CG - CD1 - NE1 ANGL. DEV. = -7.4 DEGREES REMARK 500 TRP H 207 CD1 - NE1 - CE2 ANGL. DEV. = 8.0 DEGREES REMARK 500 TRP H 207 NE1 - CE2 - CZ2 ANGL. DEV. = 10.1 DEGREES REMARK 500 TRP H 207 NE1 - CE2 - CD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP H 207 CG - CD2 - CE3 ANGL. DEV. = -5.7 DEGREES REMARK 500 TRP H 215 CG - CD1 - NE1 ANGL. DEV. = -6.7 DEGREES REMARK 500 TRP H 215 CD1 - NE1 - CE2 ANGL. DEV. = 8.0 DEGREES REMARK 500 TRP H 215 NE1 - CE2 - CZ2 ANGL. DEV. = 8.4 DEGREES REMARK 500 TRP H 215 NE1 - CE2 - CD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG H 230 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 TRP H 237 CG - CD1 - NE1 ANGL. DEV. = -7.8 DEGREES REMARK 500 TRP H 237 CD1 - NE1 - CE2 ANGL. DEV. = 8.8 DEGREES REMARK 500 TRP H 237 NE1 - CE2 - CZ2 ANGL. DEV. = 9.0 DEGREES REMARK 500 TRP H 237 NE1 - CE2 - CD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ARG H 253 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 TRP T 14 CG - CD1 - NE1 ANGL. DEV. = -7.1 DEGREES REMARK 500 TRP T 14 CD1 - NE1 - CE2 ANGL. DEV. = 7.9 DEGREES REMARK 500 TRP T 14 NE1 - CE2 - CZ2 ANGL. DEV. = 8.1 DEGREES REMARK 500 TRP T 25 CG - CD1 - NE1 ANGL. DEV. = -8.2 DEGREES REMARK 500 TRP T 25 CD1 - NE1 - CE2 ANGL. DEV. = 8.6 DEGREES REMARK 500 TRP T 25 NE1 - CE2 - CZ2 ANGL. DEV. = 7.5 DEGREES REMARK 500 TRP T 45 CG - CD1 - NE1 ANGL. DEV. = -7.3 DEGREES REMARK 500 REMARK 500 THIS ENTRY HAS 54 ANGLE DEVIATIONS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER L 52 37.28 -99.58 REMARK 500 SER L 53 69.01 14.09 REMARK 500 ASN L 57 35.20 38.33 REMARK 500 GLN L 64 -159.59 -135.97 REMARK 500 GLN L 66 -41.79 103.40 REMARK 500 PRO L 74 -32.90 -38.02 REMARK 500 CYS L 81 46.05 35.36 REMARK 500 ASP L 86 2.17 -52.73 REMARK 500 GLN L 100 -85.01 -122.74 REMARK 500 LEU H 41 -73.02 -114.86 REMARK 500 THR H 49 -30.42 -33.67 REMARK 500 SER H 54 -157.35 -140.51 REMARK 500 ALA H 56 -36.44 -38.87 REMARK 500 TRP H 61 -6.91 -47.21 REMARK 500 ASN H 63 32.75 -79.18 REMARK 500 HIS H 71 -62.63 -142.96 REMARK 500 ASP H 79 -31.67 -153.61 REMARK 500 ASP H 146 -50.12 -27.88 REMARK 500 LYS H 170D -69.15 -12.81 REMARK 500 ASP H 189 174.19 179.48 REMARK 500 ASP H 189 173.92 179.48 REMARK 500 SER H 195 139.85 -37.70 REMARK 500 ARG H 204 40.96 39.89 REMARK 500 SER H 214 -67.30 -122.82 REMARK 500 SER H 232 -36.32 -39.64 REMARK 500 PRO H 255 125.44 -32.79 REMARK 500 PHE T 19 -4.44 78.81 REMARK 500 CYS T 49 65.57 31.33 REMARK 500 TYR T 51 58.42 33.18 REMARK 500 SER T 88 -39.22 -35.87 REMARK 500 ALA T 89 35.11 -97.82 REMARK 500 ASN T 137 61.64 11.80 REMARK 500 ASN T 138 -18.89 74.55 REMARK 500 LEU T 143 -39.07 -38.49 REMARK 500 SER T 195 39.58 -81.17 REMARK 500 ASN T 199 62.16 24.66 REMARK 500 SER T 202 -145.79 -91.92 REMARK 500 THR T 203 -162.78 -109.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 NOTE THAT IN THE CRYSTAL A REACEMIC MIXTURE OF THE LIGAND REMARK 600 C1B WAS USED. THE PHENOLATE OXYGEN MAKES SHORT HYDROGEN REMARK 600 BONDS WITH THE HYDROXYL GROUP OF SER195 AND A WATER. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C1B H 258 DBREF 2B7D L 1 152 UNP P08709 FA7_HUMAN 61 212 DBREF 2B7D H 16 257 UNP P08709 FA7_HUMAN 213 466 DBREF 2B7D T 2 219 UNP P13726 TF_HUMAN 34 251 SEQRES 1 L 152 ALA ASN ALA PHE LEU GLU GLU LEU ARG PRO GLY SER LEU SEQRES 2 L 152 GLU ARG GLU CYS LYS GLU GLU GLN CYS SER PHE GLU GLU SEQRES 3 L 152 ALA ARG GLU ILE PHE LYS ASP ALA GLU ARG THR LYS LEU SEQRES 4 L 152 PHE TRP ILE SER TYR SER ASP GLY ASP GLN CYS ALA SER SEQRES 5 L 152 SER PRO CYS GLN ASN GLY GLY SER CYS LYS ASP GLN LEU SEQRES 6 L 152 GLN SER TYR ILE CYS PHE CYS LEU PRO ALA PHE GLU GLY SEQRES 7 L 152 ARG ASN CYS GLU THR HIS LYS ASP ASP GLN LEU ILE CYS SEQRES 8 L 152 VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SER ASP SEQRES 9 L 152 HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS GLU GLY SEQRES 10 L 152 TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR PRO THR SEQRES 11 L 152 VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU GLU LYS SEQRES 12 L 152 ARG ASN ALA SER LYS PRO GLN GLY ARG SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO SEQRES 1 T 218 GLY THR THR ASN THR VAL ALA ALA TYR ASN LEU THR TRP SEQRES 2 T 218 LYS SER THR ASN PHE LYS THR ILE LEU GLU TRP GLU PRO SEQRES 3 T 218 LYS PRO VAL ASN GLN VAL TYR THR VAL GLN ILE SER THR SEQRES 4 T 218 LYS SER GLY ASP TRP LYS SER LYS CYS PHE TYR THR THR SEQRES 5 T 218 ASP THR GLU CYS ASP LEU THR ASP GLU ILE VAL LYS ASP SEQRES 6 T 218 VAL LYS GLN THR TYR LEU ALA ARG VAL PHE SER TYR PRO SEQRES 7 T 218 ALA GLY ASN VAL GLU SER THR GLY SER ALA GLY GLU PRO SEQRES 8 T 218 LEU TYR GLU ASN SER PRO GLU PHE THR PRO TYR LEU GLU SEQRES 9 T 218 THR ASN LEU GLY GLN PRO THR ILE GLN SER PHE GLU GLN SEQRES 10 T 218 VAL GLY THR LYS VAL ASN VAL THR VAL GLU ASP GLU ARG SEQRES 11 T 218 THR LEU VAL ARG ARG ASN ASN THR PHE LEU SER LEU ARG SEQRES 12 T 218 ASP VAL PHE GLY LYS ASP LEU ILE TYR THR LEU TYR TYR SEQRES 13 T 218 TRP LYS SER SER SER SER GLY LYS LYS THR ALA LYS THR SEQRES 14 T 218 ASN THR ASN GLU PHE LEU ILE ASP VAL ASP LYS GLY GLU SEQRES 15 T 218 ASN TYR CYS PHE SER VAL GLN ALA VAL ILE PRO SER ARG SEQRES 16 T 218 THR VAL ASN ARG LYS SER THR ASP SER PRO VAL GLU CYS SEQRES 17 T 218 MET GLY GLN GLU LYS GLY GLU PHE ARG GLU HET C1B H 258 39 HETNAM C1B (2R)-2-[5-(5-CARBAMIMIDOYL-1H-BENZOIMIDAZOL-2-YL)-6,2'- HETNAM 2 C1B DIHYDROXY-5'-UREIDOMETHYL-BIPHENYL-3-YL]-SUCCINIC ACID FORMUL 4 C1B C26 H24 N6 O7 FORMUL 5 HOH *306(H2 O) HELIX 1 1 ASP L 86 GLN L 88 5 3 HELIX 2 2 ASN L 93 CYS L 98 5 6 HELIX 3 3 ILE L 138 GLU L 142 5 5 HELIX 4 4 ALA H 55 ASP H 60 5 6 HELIX 5 5 GLU H 125 THR H 129C 1 8 HELIX 6 6 LEU H 129D VAL H 129G 5 4 HELIX 7 7 MET H 164 SER H 170B 1 9 HELIX 8 8 TYR H 234 MET H 242 1 9 HELIX 9 9 LEU T 59 VAL T 64 1 6 HELIX 10 10 THR T 101 THR T 106 1 6 HELIX 11 11 LEU T 143 GLY T 148 1 6 HELIX 12 12 LYS T 149 LEU T 151 5 3 SHEET 1 A 2 SER L 60 ASP L 63 0 SHEET 2 A 2 TYR L 68 PHE L 71 -1 O PHE L 71 N SER L 60 SHEET 1 B 2 PHE L 76 GLU L 77 0 SHEET 2 B 2 THR L 83 HIS L 84 -1 O THR L 83 N GLU L 77 SHEET 1 C 2 TYR L 101 HIS L 105 0 SHEET 2 C 2 THR L 108 ARG L 113 -1 O ARG L 113 N TYR L 101 SHEET 1 D 2 TYR L 118 LEU L 120 0 SHEET 2 D 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119 SHEET 1 E 8 LYS H 20 VAL H 21 0 SHEET 2 E 8 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20 SHEET 3 E 8 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163 SHEET 4 E 8 GLY H 226 ARG H 230 -1 O TYR H 228 N PHE H 181 SHEET 5 E 8 THR H 206 TRP H 215 -1 N TRP H 215 O VAL H 227 SHEET 6 E 8 PRO H 198 TYR H 203 -1 N TYR H 203 O THR H 206 SHEET 7 E 8 PHE H 135 GLY H 140 -1 N LEU H 137 O ALA H 200 SHEET 8 E 8 MET H 156 LEU H 163 -1 O MET H 156 N GLY H 140 SHEET 1 F 8 LEU H 251 ALA H 254 0 SHEET 2 F 8 GLN H 81 PRO H 91 1 N VAL H 88 O LEU H 252 SHEET 3 F 8 ALA H 104 LEU H 108 -1 O LEU H 105 N ILE H 89 SHEET 4 F 8 TRP H 51 SER H 54 -1 N VAL H 52 O LEU H 106 SHEET 5 F 8 ALA H 39 ASN H 48 -1 N THR H 45 O VAL H 53 SHEET 6 F 8 GLN H 30 VAL H 35 -1 N VAL H 35 O ALA H 39 SHEET 7 F 8 LEU H 64 LEU H 68 -1 O VAL H 67 N LEU H 32 SHEET 8 F 8 GLN H 81 PRO H 91 -1 O ARG H 83 N ALA H 66 SHEET 1 G 3 TYR T 10 THR T 17 0 SHEET 2 G 3 LYS T 20 GLU T 26 -1 O ILE T 22 N LYS T 15 SHEET 3 G 3 GLU T 56 ASP T 58 -1 O CYS T 57 N LEU T 23 SHEET 1 H 4 LYS T 46 THR T 52 0 SHEET 2 H 4 GLN T 32 THR T 40 -1 N VAL T 36 O LYS T 48 SHEET 3 H 4 TYR T 71 PRO T 79 -1 O PHE T 76 N THR T 35 SHEET 4 H 4 LEU T 93 ASN T 96 -1 O LEU T 93 N SER T 77 SHEET 1 I 2 ARG T 131 ARG T 136 0 SHEET 2 I 2 THR T 139 SER T 142 -1 O LEU T 141 N THR T 132 SHEET 1 J 2 ILE T 152 TYR T 153 0 SHEET 2 J 2 ALA T 191 VAL T 192 -1 O VAL T 192 N ILE T 152 SSBOND 1 CYS L 50 CYS L 61 1555 1555 2.03 SSBOND 2 CYS L 55 CYS L 70 1555 1555 2.02 SSBOND 3 CYS L 72 CYS L 81 1555 1555 2.03 SSBOND 4 CYS L 91 CYS L 102 1555 1555 2.02 SSBOND 5 CYS L 98 CYS L 112 1555 1555 2.02 SSBOND 6 CYS L 114 CYS L 127 1555 1555 2.04 SSBOND 7 CYS L 135 CYS H 122 1555 1555 2.04 SSBOND 8 CYS H 22 CYS H 27 1555 1555 2.03 SSBOND 9 CYS H 42 CYS H 58 1555 1555 2.01 SSBOND 10 CYS H 168 CYS H 182 1555 1555 2.04 SSBOND 11 CYS H 191 CYS H 220 1555 1555 2.04 SSBOND 12 CYS T 49 CYS T 57 1555 1555 2.06 CISPEP 1 PHE H 256 PRO H 257 0 7.00 CISPEP 2 GLU T 26 PRO T 27 0 -11.75 SITE 1 AC1 19 CYS H 42 HIS H 57 ASP H 60 LYS H 60A SITE 2 AC1 19 ASP H 189 SER H 190 CYS H 191 LYS H 192 SITE 3 AC1 19 SER H 195 VAL H 213 TRP H 215 GLY H 219 SITE 4 AC1 19 CYS H 220 GLY H 226 HOH H 287 HOH H 298 SITE 5 AC1 19 HOH H 304 HOH H 385 HOH H 391 CRYST1 78.700 69.030 78.190 90.00 89.49 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012706 0.000000 -0.000113 0.00000 SCALE2 0.000000 0.014486 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012790 0.00000